New drugs and dosage forms.
D000293:Adolescent; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001058:Apomorphine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D000075202:Contraindications; D003967:Diarrhea / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D004304:Dosage Forms; D004334:Drug Administration Schedule; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012294:Rifamycins / Q000008:administration & dosage / Q000627:therapeutic use*; D000078262:Rifaximin; D014011:Tinidazole / Q000008:administration & dosage / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D000994:Antitrichomonal Agents; D018491:Dopamine Agonists; D004304:Dosage Forms; D012294:Rifamycins; D014011:Tinidazole; D000078262:Rifaximin; D001058:Apomorphine